Cleveland HeartLab acquires MIRISK cardiovascular disease assessment tool technology

January 7, 2015

Cleveland HeartLab said it has acquired a technology developed at Stanford University that can determine whether a patient is at risk for a heart attack.

Welcome to To find out more about how we use cookies and how you can change your settings, read our privacy policy